A
Aavant Research
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | A | 7 | 8.3 | 6.2 | 9.5 | 11 Aug 2025 |
| Tirzepatide | A | 6 | 9.3 | 8.1 | 10.0 | 24 Oct 2025 |
| AA Water | X | 1 | 9.2 | 9.2 | 9.2 | 2 Jul 2025 |
| ACE-031 | X | 1 | 10.0 | 10.0 | 10.0 | 9 Jun 2025 |
| AHK-CU | X | 1 | 8.8 | 8.8 | 8.8 | 9 Jun 2025 |
| AICAR | X | 1 | 7.8 | 7.8 | 7.8 | 8 Jul 2025 |
| ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | X | 1 | 7.4 | 7.4 | 7.4 | 13 Jun 2025 |
| AOD9604 | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jul 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X | 1 | 7.7 | 7.7 | 7.7 | 14 Jan 2025 |
| Botulinum toxin | X | 1 | 10.0 | 10.0 | 10.0 | 25 Apr 2025 |
| Cardiogen | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 |
| Cartalax | X | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 |
| CJC-1295 With DAC | X | 1 | 8.3 | 8.3 | 8.3 | 21 May 2025 |
| Clenbuterol | X | 1 | 7.2 | 7.2 | 7.2 | 21 May 2025 |
| Crystagen | X | 1 | 8.2 | 8.2 | 8.2 | 16 Mar 2025 |
| DNP | X | 1 | 7.7 | 7.7 | 7.7 | 9 Jun 2025 |
| Equipoise (Boldenone Undecylenate) | X | 1 | 9.4 | 9.4 | 9.4 | 25 Apr 2025 |
| Glutathione | X | 1 | 6.0 | 6.0 | 6.0 | 17 Dec 2024 |
| Hyaluronic acid | X | 1 | 9.9 | 9.9 | 9.9 | 2 Jul 2025 |
| IGF-1 LR3 | X | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 |
| Ivermectin | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X | 1 | 8.3 | 8.3 | 8.3 | 3 Jun 2025 |
| Lipo-C 120mg | X | 1 | 9.3 | 9.3 | 9.3 | 3 Jun 2025 |
| Minoxidil Oral | X | 1 | 6.7 | 6.7 | 6.7 | 6 May 2025 |
| Ostarine (MK-2866) | X | 1 | 7.7 | 7.7 | 7.7 | 6 May 2025 |
| Oxymetholone (Anadrol) Raw | X | 1 | 9.9 | 9.9 | 9.9 | 8 Jul 2025 |
| Oxytocin Acetate | X | 1 | 8.4 | 8.4 | 8.4 | 13 Jun 2025 |
| Pinealon | X | 1 | 9.8 | 9.8 | 9.8 | 13 Feb 2025 |
| PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | X | 1 | 8.4 | 8.4 | 8.4 | 13 Jun 2025 |
| Prostamax | X | 1 | 8.8 | 8.8 | 8.8 | 17 Dec 2024 |
| Proviron (Mesterolone) | X | 1 | 9.5 | 9.5 | 9.5 | 21 May 2025 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X | 1 | 7.6 | 7.6 | 7.6 | 13 Jun 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X | 1 | 8.2 | 8.2 | 8.2 | 13 Feb 2025 |
| Salbutamol | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jul 2025 |
| Semax | X | 1 | 9.5 | 9.5 | 9.5 | 17 Dec 2024 |
| SS-31 | X | 1 | 9.3 | 9.3 | 9.3 | 21 May 2025 |
| Super Shred | X | 1 | 7.2 | 7.2 | 7.2 | 7 May 2025 |
| Sustanon 400 | X | 1 | 8.4 | 8.4 | 8.4 | 27 Feb 2025 |
| Thymalin | X | 1 | 8.6 | 8.6 | 8.6 | 7 May 2025 |
| Tren Hex | X | 1 | 6.0 | 6.0 | 6.0 | 28 Mar 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 24 May 2026 | ACE-031 | 9.9 | 2mg | 2.0mg | -1.3% | 98.92% | Lab G |
| 24 May 2026 | Cartalax | 7.9 | 30mg | 26.7mg | -11.1% | 95.42% | Lab C |
| 24 May 2026 | CJC-1295 With DAC | 7.5 | 50mg | 43.7mg | -12.6% | 95.59% | Lab F |
| 24 May 2026 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 4.9 | 500g | 555.9g | +11.2% | 97.72% | Lab C |
| 24 May 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 7.9 | 300mg/ml | 262.8mg/ml | -12.4% | 98.37% | Lab A |
| 24 May 2026 | Minoxidil Oral | 6.8 | 50mg | 46.8mg | -6.5% | 98.35% | Lab G |
| 24 May 2026 | Retatrutide | 9.4 | 24mg | 25.7mgpackage | 24.9mg | -3.3% | No Label / Silver Crimp / Red Cap |
| 24 May 2026 | Super Shred | 6.6 | 100mg/ml | 95.8mg/ml | -4.2% | 98.12% | Lab B |
| 24 May 2026 | AICAR | 8.0 | 30mg | 36.0mg | +20.0% | 98.59% | Lab F |
| 24 May 2026 | AHK-CU | 7.7 | 30mg | 31.8mg | +6.1% | 98.80% | Lab C |
| 24 May 2026 | Lipo-C 120mg | 8.8 | 100mg/ml | 115.3mg/ml | +15.3% | 96.29% | Lab E |
| 24 May 2026 | SS-31 | 9.2 | 5mg | 5.2mg | +3.6% | 97.96% | Lab C |
| 23 May 2026 | Pinealon | 8.6 | 2mg | 1.8mg | -11.3% | 96.37% | Lab A |
| 23 May 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 7.7 | 500g | 520.1g | +4.0% | 95.60% | Lab G |
| 23 May 2026 | Clenbuterol | 8.3 | 10mg | 9.3mg | -6.7% | 97.83% | Lab D |
| 21 May 2026 | DNP | 7.3 | 25mg | 22.9mg | -8.3% | 98.69% | Lab A |
| 20 May 2026 | Crystagen | 8.8 | 50mg | 56.4mg | +12.7% | 96.87% | Lab D |
| 19 May 2026 | Retatrutide | 8.1 | 12mg | (no batch claim) | 13.4mg | +11.7% | Silver Label / Silver Crimp / Black Cap |
| 17 May 2026 | Oxymetholone (Anadrol) Raw | 8.3 | 500g | 507.7g | +1.5% | 97.65% | Lab B |
| 17 May 2026 | Sustanon 400 | 7.7 | 100mg/ml | 120.5mg/ml | +20.5% | 97.76% | Lab D |
| 29 Jan 2026 | Ivermectin | 8.0 | 50mg | 59.8mg | +19.6% | 95.75% | Lab C |
| 26 Jan 2026 | Semax | 9.3 | 30mg | 30.3mg | +0.9% | 95.98% | Lab G |
| 26 Jan 2026 | Tren Hex | 6.5 | 200mg/ml | 212.0mg/ml | +6.0% | 95.30% | Lab D |
| 19 Jan 2026 | IGF-1 LR3 | 8.3 | 20mg | 20.2mg | +0.9% | 98.33% | Lab G |
| 19 Jan 2026 | Prostamax | 8.9 | 20mg | 19.2mg | -4.0% | 97.97% | Lab C |
| 9 Jan 2026 | Glutathione | 6.9 | 20mg | 24.8mg | +23.8% | 98.84% | Lab E |
| 7 Jan 2026 | Retatrutide | 9.5 | 11mg | (no batch claim) | 10.9mg | -0.9% | Silver Label / Silver Crimp / Black Cap |
| 7 Jan 2026 | Tirzepatide | 9.8 | 29.93mg | (no batch claim) | 31.4mg | +4.9% | Silver Label / Black Crimp / Pink Cap |
| 7 Jan 2026 | Tirzepatide | 9.8 | 60mg | (no batch claim) | 61.6mg | +2.7% | Silver Label / Teal Crimp / Clear Pink Cap |
| 6 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 8.9 | 30mg | 27.3mg | -9.0% | 98.57% | Lab G |
| 6 Jan 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 7.6 | 50mg | 53.9mg | +7.7% | 99.30% | Lab G |
| 6 Jan 2026 | RIPEX 225 (TRA/Mast P/Test P) | 8.6 | 100mg/ml | 110.5mg/ml | +10.5% | 98.56% | Lab C |
| 29 Dec 2025 | Ostarine (MK-2866) | 9.2 | 50mg | 59.0mg | +18.0% | 98.03% | Lab E |
| 12 Dec 2025 | AOD9604 | 7.7 | 50mg | 56.4mg | +12.8% | 96.27% | Lab F |
| 12 Dec 2025 | Thymalin | 9.7 | 2mg | 2.0mg | -1.1% | 99.44% | Lab C |
| 5 Dec 2025 | Botulinum toxin | 9.2 | 15mg | 14.9mg | -0.6% | 97.80% | Lab C |
| 5 Dec 2025 | Hyaluronic acid | 10.0 | 20mg | 24.2mg | +21.0% | 95.38% | Lab A |
| 18 Nov 2025 | Tirzepatide | 9.7 | 25mg | (no batch claim) | 24.6mg | -1.6% | White Label / Silver Crimp / Clear Blue Cap |
| 17 Nov 2025 | Tirzepatide | 8.1 | 25mg | 28.0mgwebsite | 25.9mg | -7.6% | No Label / Silver Crimp / Clear Blue Cap |
| 17 Nov 2025 | Oxytocin Acetate | 8.0 | 30mg | 31.2mg | +4.0% | 99.47% | Lab B |
| 4 Nov 2025 | AA Water | 9.4 | 15mg | 15.2mg | +1.3% | 98.42% | Lab F |
| 9 Oct 2025 | Cardiogen | 10.0 | 30mg | 31.5mg | +5.1% | 95.20% | Lab E |
| 9 Oct 2025 | Equipoise (Boldenone Undecylenate) | 9.0 | 200mg/ml | 185.2mg/ml | -7.4% | 98.24% | Lab E |
| 9 Oct 2025 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 10.0 | 100mg/ml | 123.8mg/ml | +23.8% | 95.94% | Lab F |
| 9 Oct 2025 | Salbutamol | 10.0 | 10mg | 9.1mg | -8.7% | 96.02% | Lab E |
| 3 Oct 2025 | Proviron (Mesterolone) | 10.0 | 25mg | 30.7mg | +22.6% | 96.33% | Lab D |